Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$51.77
+0.1%		$46.06
$42.20
▼
$109.50
$75.11B0.5620.25 million shs16.28 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$89.75
-1.9%		$76.08
$54.11
▼
$91.96
$33.87B1.415.45 million shs3.86 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$394.51
-1.7%		$391.45
$328.57
▼
$603.88
$139.37B1.464.06 million shs1.99 million shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-0.03%+4.89%+20.18%-1.71%-49.53%
DexCom, Inc. stock logo
DXCM
DexCom
-1.89%+5.90%+23.40%+45.63%+12.24%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-1.68%+4.14%+1.42%-6.32%-18.21%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$51.77
+0.1%		$46.06
$42.20
▼
$109.50
$75.11B0.5620.25 million shs16.28 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$89.75
-1.9%		$76.08
$54.11
▼
$91.96
$33.87B1.415.45 million shs3.86 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$394.51
-1.7%		$391.45
$328.57
▼
$603.88
$139.37B1.464.06 million shs1.99 million shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-0.03%+4.89%+20.18%-1.71%-49.53%
DexCom, Inc. stock logo
DXCM
DexCom
-1.89%+5.90%+23.40%+45.63%+12.24%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
-1.68%+4.14%+1.42%-6.32%-18.21%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.71
Moderate Buy$71.6238.34% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.89
Moderate Buy$88.71-1.16% Downside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.68
Moderate Buy$508.6828.94% Upside

Current Analyst Ratings Breakdown

Latest ISRG, DXCM, and BSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Sanford C. Bernstein logo
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform
8/12/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
8/12/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$500.00
8/11/2026
DexCom, Inc. stock logo
DXCM
DexCom
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/4/2026
DexCom, Inc. stock logo
DXCM
DexCom
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$86.00 ➝ $96.00
8/3/2026
DexCom, Inc. stock logo
DXCM
DexCom
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$82.00 ➝ $90.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingStrong-Buy$94.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$88.00 ➝ $95.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$105.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$84.00 ➝ $88.00
(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$20.07B3.74$4.03 per share12.84$17.37 per share2.98
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B7.26$2.77 per share32.41$6.95 per share12.91
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B13.85$9.28 per share42.52$51.79 per share7.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.4720.9615.141.1317.50%19.28%10.89%10/28/2026 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5335.4729.141.5120.12%35.94%14.75%10/29/2026 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.7345.1939.452.8528.45%16.91%14.83%10/20/2026 (Estimated)

Latest ISRG, DXCM, and BSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6110$0.70+$0.0890$0.64$1.29 billion$1.31 billion
7/29/2026Q2 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.83$0.86+$0.03$0.61$5.38 billion$5.44 billion
7/16/2026Q2 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.48$2.80+$0.32$2.29$2.83 billion$2.89 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.43
1.24
0.74
DexCom, Inc. stock logo
DXCM
DexCom
0.47
1.73
1.43
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.96
3.91

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%

Insider Ownership

CompanyInsider Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.45 billion1.44 billionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000377.36 million376.30 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021353.28 million351.16 millionOptionable

Recent News About These Companies

Intuitive Surgical (NASDAQ:ISRG) Rating Lowered to Hold at Wall Street Zen
August 15 at 1:43 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30961430
Wall Street Zen Downgrades Intuitive Surgical (NASDAQ:ISRG) to Hold
August 15 at 1:41 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/wall-street-zen-downgrades-intuitive-surgical-nasdaqisrg-to-hold-2026-08-15/
New Bill: Representative Val T. Hoyle introduces H.R. 10094: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
August 14 at 11:50 AM  |  quiverquant.comQ
Intuitive Surgical (NASDAQ:ISRG) Raised to "Outperform" at Oppenheimer
August 14 at 2:36 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30959751
What Puts Intuitive Surgical (NASDAQ:ISRG) At The Center of Surgical Robotics?
August 13 at 9:36 PM  |  kalkinemedia.comK
Intuitive is successfully crowding out competitors, analysts say
August 13 at 9:36 PM  |  massdevice.comhttps://www.massdevice.com/intuitive-is-successfully-crowding-out-competitors-analysts-say/
Intuitive Surgical (ISRG) Backs Long-Term Moat Amid Near-Term Volatility
August 13 at 11:51 AM  |  insidermonkey.comhttps://www.insidermonkey.com/blog/intuitive-surgical-isrg-backs-long-term-moat-amid-near-term-volatility-1809968/
Intuitive Surgical (ISRG) Backs Long-Term Moat Amid Near-Term Volatility
August 13 at 11:35 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/intuitive-surgical-isrg-backs-long-133733648.html
Intuitive Surgical (NASDAQ:ISRG) Director Gary Guthart Sells 10,000 Shares of Stock
August 13 at 6:36 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-isrg-insider-buying-and-selling-2026-08-13/
The Paid-To-Hold Play On ISRG Stock: A 12% Annualized Income
August 12 at 10:43 PM  |  trefis.comT
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?
August 12 at 3:36 PM  |  zacks.comhttps://www.zacks.com/stock/news/2973840/isrg-s-us-procedure-growth-slows-is-aca-headwind-a-temporary-concern?cid=cs-stocknewsapi-ft-analyst_blog|quick_take-2973840
Insider Selling: Intuitive Surgical (NASDAQ:ISRG) Director Sells $4,000,000.00 in Stock
August 12 at 3:06 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-selling-intuitive-surgical-nasdaqisrg-director-sells-400000000-in-stock-2026-08-12/
Intuitive Surgical’s ENCOMPASS Trial Puts Robotic Lung Biopsy in the Spotlight
August 12 at 12:50 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/intuitive-surgicals-encompass-trial-puts-robotic-lung-biopsy-in-the-spotlight?utm_source=marketbeat.com&utm_medium=referral
Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall
August 12 at 12:42 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/oppenheimer-sees-500-intuitive-surgical-122519688.html
If You Invested $1000 in Intuitive Surgical, Inc. 10 Years Ago, This Is How Much You'd Have Now
August 12 at 12:42 PM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/invested-1000-intuitive-surgical-inc-123002658.html
Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"
August 12 at 12:42 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/intuitive-surgical-oppenheimer-now-bullish-125931309.html
Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.
August 12 at 12:42 PM  |  fool.comhttps://www.fool.com/investing/2026/08/12/intuitive-surgical-isrg-has-plunged-why-one-fund/
Intuitive Surgical's Competitors Face Challenges That Limit Long-Term Appeal, Oppenheimer Says
August 12 at 12:42 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/intuitive-surgical-apos-competitors-face-153642167.html
Intuitive Surgical: Priced For Precision
August 12 at 11:11 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4935378-intuitive-surgical-priced-for-precision?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Intuitive Surgical: Buy Rating Reiterated as New GI Platform Progress Supports Growth; $685 Price Target Maintained
August 12 at 9:51 AM  |  tipranks.comhttps://www.tipranks.com/news/ratings/intuitive-surgical-buy-rating-reiterated-as-new-gi-platform-progress-supports-growth-685-price-target-maintained-ratings-news?utm_source=marketbeat.com&utm_medium=referral
Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More
August 12 at 8:11 AM  |  247wallst.comhttps://247wallst.com/investing/2026/08/12/here-are-wednesdays-top-wall-street-analyst-research-calls-the-gap-genmab-hilton-worldwide-intuitive-surgical-mariott-international-merck-novo-nordisk-okta-and-more/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Two Very Large Crude Carriers (VLLCs) sailing side by side on open ocean waters, viewed from above.
Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
By Dan Schmidt | July 19, 2026
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
Robotic surgical arms from a da Vinci system surround the Intuitive logo in a circular arrangement.
Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
By Chris Markoch | July 18, 2026
Boston Scientific stock logo

Boston Scientific NYSE:BSX

$51.77 +0.08 (+0.15%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$52.32 +0.55 (+1.07%)
As of 08/14/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

DexCom stock logo

DexCom NASDAQ:DXCM

$89.75 -1.73 (-1.89%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$89.26 -0.49 (-0.55%)
As of 08/14/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$394.51 -6.76 (-1.68%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$394.86 +0.35 (+0.09%)
As of 08/14/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas